Ερευνητικό υλικό ΕΚΠΑ

A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study

Αγγλικά

Objectives A prospective international multicentre surveillance study was conducted to investigate the prevalence and amphotericin B susceptibility of Aspergillus terreus species complex infections. Methods A total of 370 cases from 21 countries were evaluated. Results The overall prevalence of A. terreus species complex among the investigated patients with mould-positive cultures was 5.2% (370/7116). Amphotericin B MICs ranged from 0.125 to 32 mg/L, (median 8 mg/L). Conclusions Aspergillus terreus species complex infections cause a wide spectrum of aspergillosis and the majority of cryptic species display high amphotericin B MICs. © 2017

2017

Risslegger, B.
Zoran, T.
Lackner, M.
Aigner, M.
Sánchez-Reus, F.
Rezusta, A.
Chowdhary, A.
Taj-Aldeen, S.J.
Arendrup, M.C.
Oliveri, S.
Kontoyiannis, D.P.
Alastruey-Izquierdo, A.
Lagrou, K.
Lo Cascio, G.
Meis, J.F.
Buzina, W.
Farina, C.
Drogari-Apiranthitou, M.
Grancini, A.
Tortorano, A.M.
Willinger, B.
Hamprecht, A.
Johnson, E.
Klingspor, L.
Arsic-Arsenijevic, V.
Cornely, O.A.
Meletiadis, J.
Prammer, W.
Tullio, V.
Vehreschild, J.-J.
Trovato, L.
Lewis, R.E.
Segal, E.
Rath, P.-M.
Hamal, P.
Rodriguez-Iglesias, M.
Roilides, E.
Arikan-Akdagli, S.
Chakrabarti, A.
Colombo, A.L.
Fernández, M.S.
Martin-Gomez, M.T.
Badali, H.
Petrikkos, G.
Klimko, N.
Heimann, S.M.
Houbraken, J.
Uzun, O.
Edlinger, M.
Fuente, S.D.L.
Lass-Flörl, C.

Clinical Microbiology and Infection

Elsevier B.V.

23

10

776.e1-776.e5

amphotericin B; amphotericin B lipid complex; echinocandin; pyrrole derivative; amphotericin B; antifungal agent, allergic bronchopulmonary aspergillosis; antifungal susceptibility; antifungal therapy; Article; aspergilloma; aspergillosis; Aspergillus; Aspergillus alabamensis; Aspergillus citrinoterreus; Aspergillus floccosus; Aspergillus hortai; Aspergillus neoafricanus; Aspergillus terreus; chronic obstructive lung disease; Europe; external otitis; human; in vitro study; invasive aspergillosis; major clinical study; Middle East; minimum inhibitory concentration; multicenter study; nonhuman; North America; onychomycosis; priority journal; prospective study; South America; wound infection; aspergillosis; classification; clinical trial; drug effect; epidemiological monitoring; isolation and purification; microbial sensitivity test; microbiology; prevalence, Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Epidemiological Monitoring; Europe; Humans; Microbial Sensitivity Tests; Prevalence; Prospective Studies

https://doi.org/10.1016/j.cmi.2017.04.012

10.1016/j.cmi.2017.04.012

https://pergamos.lib.uoa.gr/uoa/dl/object/3108304